You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 213 No. 9, August 31, 1970 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of Amantadine in Artificially Induced A2 and B Influenza

A. A. Smorodintsev, MD; D. M. Zlydnikov, MD; A. M. Kiseleva; J. A. Romanov; A. P. Kazantsev; V. I. Rumovsky

JAMA. 1970;213(9):1448-1454.


Abstract

In double-blind placebo-controlled studies of 404 volunteers, amantadine hydrochloride was found to be 51% effective in preventing the development of artificially induced A2 influenza, and 73% to 92% effective in preventing the more severe form of A2 influenza. Milder disease was seen in those who developed A2 influenza in spite of amantadine therapy. Serological responses were also reduced. No significant difference was observed either between once- and twice-daily dosage or between 200 mg and 100 mg/day regimens. No benefit was observed when the start of medication was delayed until symptoms of influenza developed. Amantadine was ineffective against B influenza. No safety problem was evident in any subject.



Author Affiliations

From the All-Union Research Institute of Influenza, Leningrad.


Footnotes

Reprint requests to All-Union Research Institute of Influenza, Leningrad P-22 (Prof Smorodintsev).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
Carrat et al.
Am J Epidemiol 2008;167:775-785.
ABSTRACT | FULL TEXT  

Influenza: vaccination and treatment
Stephenson and Nicholson
Eur Respir J 2001;17:1282-1293.
ABSTRACT | FULL TEXT  

Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract
Fenton et al.
Antimicrob. Agents Chemother. 1999;43:2642-2647.
ABSTRACT | FULL TEXT  

Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza: Randomized Controlled Trials for Prevention and Treatment
Hayden et al.
JAMA 1999;282:1240-1246.
ABSTRACT | FULL TEXT  

Chemotherapeutic control of influenza
Stephenson and Nicholson
J Antimicrob Chemother 1999;44:6-10.
FULL TEXT  

Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
Hayden et al.
JAMA 1996;275:295-299.
ABSTRACT  

Control of Influenza in the Hospital
HOFFMAN and DIXON
ANN INTERN MED 1977;87:725-728.
ABSTRACT  

Prevention and Control of Influenza by Chemoprophylaxis and Chemotherapy: Prospects From Examination of Recent Experience
Jackson and Stanley
JAMA 1976;235:2739-2742.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.